Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    Apotex
    >
    Apotex
    >
    Page 2

    Tag: Apotex

    August 29, 2013in Advisory Board, Announcements, Copyright, Copyright Reform, events, Feature Post, Freedom of Speech, Freedom of the Press, Innovation, Internet, IP, IP Intensive, IP Reform, Patents, Technology, Trademarks0by Editor
    1600

    Announcing the 2013 IP Intensive Program

    We are pleased to announce details of the 2013 Intellectual Property Law and Technology Intensive Program.  The tremendously successful program is currently in its third year, but it is continuing…

    Read more
    July 24, 2013in Canada, Feature Post, Infringement, IP, Patents, Pharmaceutical Drugs3by Editor
    2234

    Court Grants Largest Patent Infringement Damages Award in Canadian History

    On July 16, 2013, the Federal Court released its decision granting the largest award of damages for patent infringement in Canadian history.  In Merck & Co., Inc. v. Apotex Inc.…

    Read more
    May 21, 2013in Copyright, Copyright Reform, European Union, IP, IP Reform, Patents, Pharmaceutical Drugs, Supreme Court of Canada, Trademarks, US, US-Canada Relations, WIPO0by Editor
    1676

    A Cautionary Kudos: Canada Moves Up on USTR IP Watch List

    Earlier this month, the United States Trade Representative (USTR) released its annual “Special 301 Report,” which evaluates the intellectual property rights (IPR) protection and enforcement of its trading partners. Over…

    Read more
    July 23, 2012in Patentability, Patents, Pharmaceutical Drugs2by Editor
    1596

    Allergan Inc. c. Canada (Health), 2012 FC 767: Comity or Tragedy?

    A somewhat confusing victory for Allergan Inc. was won on June 18th, as the Honourable Justice Hughes upheld their patent on COMBIGAN despite the fact that their invention was ruled…

    Read more
    December 20, 2011in Patents, Patents Course Topic, Pharmaceutical Drugs1by Editor
    1350

    Sound Prediction & The Case For Xalatan®

    Lena Vartanian is a JD candidate at Osgoode Hall Law School and is enrolled in Professor Mgbeoji’s Patents class in Fall 2011. As part of the course requirements, students are…

    Read more

    Posts navigation

    1 2
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736